Artiva Biotherapeutics, Inc.
ARTV
$11.78
$0.564.99%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/11/2026
-
The Cerbat Gem
8/11/2026
-
MarketBeat
8/10/2026
-
The Cerbat Gem
8/8/2026
-
MarketBeat
8/7/2026
-
MarketBeat
8/6/2026
-
TipRanks: TheFly
8/6/2026
-
TipRanks: TheFly
8/6/2026
-
Globe Newswire
8/6/2026
-
TipRanks
7/29/2026
-
MarketBeat
7/28/2026
-
MarketBeat
7/28/2026
-
MarketBeat
7/28/2026
-
MarketBeat
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7/17/2026
-
Globe Newswire
7/15/2026
-
MarketBeat
7/14/2026
-
MarketBeat
7/5/2026
-
The Cerbat Gem
7/2/2026
-
The Cerbat Gem
6/29/2026
-
MarketBeat
6/29/2026
-
MarketBeat
6/23/2026
-
Globe Newswire
6/16/2026
-
MarketBeat
6/12/2026
-
The Cerbat Gem
6/10/2026
-
The Cerbat Gem
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 8, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 267 4467
Address
5505 Morehouse Drive
Suite 100
San Diego, CA 92121
Suite 100
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers...
more